WebTotal cholesterol, HDL-cholesterol, and non-HDL-cholesterol concentrations should be checked 3 months after starting treatment with a high-intensity statin. For statin intensity categorisation, see Dyslipidaemias. A Strength of recommendation: High. Aiming for a reduction in non-HDL-cholesterol concentration of greater than 40% is recommended. WebNov 18, 2024 · This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment …
Recommendations Familial hypercholesterolaemia: identification ... - NICE
WebFeb 15, 2024 · Besides improving cholesterol, statins are also associated with a lower risk of heart disease and stroke, which are common comorbidities in diabetes. 4. People with diabetes are twice as likely to have heart disease or a stroke compared to someone who doesn’t have diabetes—and at a younger age. 5 The risk for developing heart disease ... Weba review of 176 studies (112 RCTs and 64 cohort studies, n=4,143,517) found a prevalence of statin intolerance of 9.1% (4) statin lipid solutbility did not affect prevalence, but age, female gender, diabetes, hypothyroidism and Asian or Black race were associated with statin intolerance; See linked management algorithm. Reference: 1. highfitech min multi surface cream
Statins and Diabetes: Risks and Benefits - Verywell Health
WebJan 28, 2016 · The absence of an evidence base for the use of statins in people with type 1 diabetes is acknowledged in the section on research recommendations of the NICE guideline, and is recommended as an … WebThe recommendation on choice of statin therapy is based on the NICE ... is the most clinically- and cost-effective option for the primary and secondary prevention of CVD in people with type 2 diabetes. NICE did not identify any head-to-head trials on the … Web20 mg (24%) 40 mg (29%) Simvastatin. 10 mg (27%) Advice from the MHRA: there is an increased risk of myopathy associated with high-dose (80 mg) simvastatin. The 80 mg dose should be considered only in patients with severe hypercholesterolaemia and high risk of cardiovascular complications who have not achieved their treatment goals on lower ... high fistula output